3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
4
Unknown
2
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
28
Neoplasm Metastasis
3
Triple Negative Breast Neoplasms
2
Neoplasms
2
Uterine Cervical Neoplasms
1
Patient Compliance
1
Ovarian Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Breast Neoplasm Female
1
Breast Cancer Metastatic
1
Advanced Breast Cancer
1
Interventions
Letrozole
2
Goserelin
2
Fulvestrant
2
olaparib
1
abemaciclib
1
Trastuzumab
1
Lead
1
Aromatase Inhibitors
1
Anastrozole
1
Alpelisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Advanced Breast Cancer
×
Anastrozole
×
Clear all
NCT04714619
2023-12-19
CAILA
MedSIR
Phase 2
Terminated
2 enrolled